MedPath

Agili-C Implant Performance Evaluation in the Repair of Cartilage and OCD

Withdrawn
Conditions
articular cartilage lesion
articular cartilage defect
10023213
Registration Number
NL-OMON42688
Lead Sponsor
CartiHeal (2009) Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1. 18 years or older
2. Cartilage lesion of the operated knee graded up to grade III according to the Kelgren- Lawrence scale with known ICRS IIIa * IVb lesion (s) on the femoral condyles or the trochlea, not eligible for microfracture and who failed conservative treatment
3. The total area of the treated lesions is up to 6 cm2
4. KOOS pain score at baseline is not less than 30 and not more than 65
5. Must be physically and mentally willing and able to comply with post-operative rehabilitation and routinely scheduled clinical and radiographic visits.
6. Informed consent signing

Exclusion Criteria

1. Untreated ACL and/or PCL, ACL and/or PCL deficiency or ligamentous instability in involved knee
2. Misalignments larger than 5° from neutral that are not correctable
3. Any known tumor of the ipsilateral knee
4. Any history of infection of the treated knee
5. Inflammatory arthropathy or crystal-deposition arthropathy
6. Tobacco user
7. Systemic cartilage and/or bone disorder e.g. but not limited to chondrodysplasia or osteogenesis imperfecta
8. Body mass index >35
9. Osteoarthritis of the operated knee graded as 4 according to the Kelgren-Lawrence scale
10. Chemotherapy treatment in the past 12 months
11. Any previous surgical cartilage treatment within the last 6 months
12. History of allergic reaction or intolerance of materials containing calcium carbonate or hyaluronate
13. Patient who is pregnant or intends to become pregnant during the year following initial enrollment
14. History of any significant systemic disease, such as but not limited to, HIV infection, hepatitis infection or HTLV
infection; known coagulopathies, that might compromise the Subject's welfare
15. Known Substance abuse or alcohol abuse
16. Participation in other clinical trials in parallel to this study
17. Known insulin dependent diabetes mellitus
18. Unable to undergo MRI or X-ray

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The KOOS Pain Subscale relative to baseline [time frame: 6, 12,18 and 24 months</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>* Improvement in IKDC Subjective Knee Score relative to baseline [time frame:<br /><br>6, 12,18 and 24 months]<br /><br>* Joint Space maintenance rate according to X-ray [time frame: 12 and 24 months]<br /><br>* Improvement in other KOOS subscales relative to baseline [time frame: 6,<br /><br>12,18 and 24 months]<br /><br>* Improvement SF -36 Survey [time frame: 6, 12,18 and 24 months]<br /><br>* Improvement in Tegner score [time frame: 6, 12,18 and 24 months]<br /><br>* Improvement in Lysholm Score [time frame: 6, 12,18 and 24 months]<br /><br>* Defect Fill according to MRI [time frame: 6, 12, 18 and 24 months]D</p><br>
© Copyright 2025. All Rights Reserved by MedPath